NCT05643742
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05643742
Title A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors CRISPR Therapeutics AG
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
University of Kansas RECRUITING Westwood Kansas 66205 United States Details
Washington University RECRUITING St Louis Missouri 63110 United States Details
SCRI RECRUITING San Antonio Texas 78229 United States Details
University of Utah RECRUITING Salt Lake City Utah 84112 United States Details
Royal Prince Alfred RECRUITING Camperdown New South Wales 2050 Australia Details
Alfred Health RECRUITING Melbourne Victoria 3004 Australia Details
Sir Charles Gairdner Hospital RECRUITING Nedlands Western Australia 6009 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field